This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Hypertension, Ahead of Print. Individuals with lower income, lower educational attainment, and those with Medicaid or no insurance were significantly less likely to report attending a postpartum visit. Among those who reported attending a postpartum visit, only 56.3% reported receiving postpartum counseling on healthy lifestyle, 60.9%
Centers for Medicare & Medicaid Services (CMS) have granted the company’s Paradise Ultrasound Renal Denervation system a Transitional Pass-through (TPT) payment. Food and Drug Administration (FDA) approved Recor’s Paradise Ultrasound Renal Denervation system for the treatment of hypertension on Nov. 1, 2024 — Recor Medical, Inc.
(MedPage Today) -- The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation for patients with hypertension, Medtronic announced. The FDA said Philips is recalling the monitoring.
BackgroundThis real‐world evaluation considers an algorithm designed to detect patients with potentially undiagnosed hypertension, receiving routine care, in a large health system in Hawaiʻi. had been diagnosed with hypertension, 2.7% had no evidence of hypertension. Among the eligible patients (N=13 364), 52.6%
We then evaluated changes among low-income adults in Medicaid expansion versus non-expansion states using a similar approach.Results:The unweighted study population included 80,767 low-income and 184,136 high income adults. Treatment for hypertension (RR 1.05 [1.02-1.08]) 1.12]), access to a provider (RR 1.12 [1.09-1.14]),
1.39]), Medicaid insurance (1.16 [1.06-1.27]), 1.41]), hypertension (1.15 [1.05-1.25]), groups were more likely to be older, males, Black or Asian race, Medicaid insurance, lower income, and more comorbidities. The AIS patients in the LKWA>4.5 1.32]), males (1.10 [1.03-1.17]), 1.17]), Black (1.20 [1.08-1.33]),
Baseline, 6- and 12-month BP was measured according to AHA guidelines with BP control defined as no hypertension present or if follow-up BP was within normal range. We grouped baseline household arrangements as nuclear, multigeneration, spouse, alone, or other and household communication as engaging in conversations about stroke or not.
A logistic regression model was adjusted for age, sex, race, mechanical ventilation, systolic blood pressure, smoking status, diabetes mellitus, atrial fibrillation, hypertension, congestive heart failure, Glasgow Coma Scale, ICH location (side and deep), ICH volume on CT, and presence of intraventricular hemorrhage.
Part 1: Concepts, Indicator Variables, and Controversies The Annals of Thoracic Surgery January 2022 Arman Kilic Supplementing Existing Societal Risk Models for Surgical Aortic Valve Replacement With Machine Learning for Improved Prediction Journal of the American Heart Association November 2021 Jared Belle Strategies for Mechanical Right Ventricular (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
13, 2025 Medtronic plc recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension.
13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension. TCT 2024 4 WHO.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content